Upcoming CLL Educational Events

The varied educational activities offered by CLL Society are your opportunities to learn basic information, dive deep into specific topics, or stay abreast of cutting-edge news and research presented in the form of webinars, educational forums, and other learning modules.

FEATURED EVENT

UPCOMING CLL PATIENT EDUCATION EVENTS

CLL Society Virtual Events

Wednesday, July 22, 2026, at 9:00 AM PT / 12:00 PM ET

Join CLL Society for the webinar Medicare Part D in 2026: What Patients Need to Know. Changes to Medicare rules, plan incentives, and financial responsibility can directly impact access to the treatment your doctor recommends. Join us to learn how Part D plans may be responding to these changes, what it means if you are told your plan “denied” coverage for your CLL treatment, and practical steps you can take to appeal, navigate barriers, and advocate for the care you need.

Wednesday, August 26, 2026, at 12:30 PM PT / 3:30 PM ET

Join CLL Society for the webinar Understanding the Numbers: A Patient’s Guide to CLL / SLL Testing and Imaging. This webinar will provide a practical overview of the most common tests used in CLL / SLL care and help participants better understand what the results may mean. Discussion will include interpreting blood work and lab results, MRD (measurable residual disease) testing, mutation and genetic testing, imaging scans such as CT, MRI, and PET scans, bone marrow biopsies, and why certain tests are important before starting treatment.

Other Virtual Events

Triage Cancer

Upcoming Triage Cancer Webinars

Lymphoma Research Foundation

Upcoming Lymphoma Research Foundation Events
Thursday, July 30, 2026, at 11:00 AM PT / 2:00 PM ET
Join LRF for the webinar Update on Chronic Lymphocytic Leukemia/Small Lympocytic Lymphoma (CLL / SLL). This session will cover the symptoms, staging, and diagnosis of CLL / SLL, along with coping strategies during active surveillance and an overview of first-line and later-line treatment options, including targeted therapies, immunotherapy, and cellular therapy. It will also highlight the role of measurable residual disease (MRD) testing and provide guidance on managing symptoms, side effects, and ongoing follow-up care.
 
Tuesday, August 11, 2026, at 1:30 PM PT / 4:30 PM ET
Join LRF for Ask the Doctor About Lymphoma: Navigating Relapsed/Refractory Disease. This program will provide patients with information on what to consider if their lymphoma or CLL / SLL has returned or is not responding to initial treatment.
 
Tuesday, September 1, 2026, at 11:00 AM PT / 2:00 PM ET
Join LRF for the webinar Developing New Treatments for Lymphoma and CLL: The Role of Clinical Trials and Patient Advocacy. This session will cover the impact of research on the treatment landscape and patient outcomes in lymphoma and CLL; discuss how to determine research goals and design a clinical trial; and evaluate the safety and effectiveness of new lymphoma treatments and combinations. Additionally, a patient and research advocate will share more about the patient voice in drug development and regulation.
 

Updated July 13, 2026